申请人:Abbott Laboratories
公开号:US06693136B1
公开(公告)日:2004-02-17
Compounds of formula (I)
are novel P2X3 and P2X2/P2X3 containing receptor antagonists and are useful in treating pain, urinary incontinence, and bladder overactivity.
公式(I)的化合物是新颖的P2X3和P2X2 / P2X3受体拮抗剂,可用于治疗疼痛,尿失禁和膀胱过度活动。